These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 24124704)

  • 1. Common Gastrointestinal Symptoms: dyspepsia and Helicobacter pylori.
    Fashner J; Gitu AC
    FP Essent; 2013 Oct; 413():24-8. PubMed ID: 24124704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines in the medical treatment of Helicobacter pylori infection.
    Dzieniszewski J; Jarosz M
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia.
    De Francesco V; Della Valle N; Stoppino V; Amoruso A; Muscatiello N; Panella C; Ierardi E
    Aliment Pharmacol Ther; 2004 May; 19(9):993-8. PubMed ID: 15113366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
    Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
    Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Should we take into account Helicobacter pylori infection in a patient with dyspeptic symptoms?].
    Jian R; Coffin B
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):432-9. PubMed ID: 12700500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
    Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O
    N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori and non-malignant diseases.
    Matysiak-Budnik T; Laszewicz W; Lamarque D; Chaussade S
    Helicobacter; 2006 Oct; 11 Suppl 1():27-31. PubMed ID: 16925608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
    J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori and Nonmalignant Diseases.
    Potamitis GS; Axon AT
    Helicobacter; 2015 Sep; 20 Suppl 1():26-9. PubMed ID: 26372821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for treatment of Helicobacter pylori infection: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori and nonmalignant diseases.
    Kuipers EJ; Malfertheiner P
    Helicobacter; 2004; 9 Suppl 1():29-34. PubMed ID: 15347303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.
    Jarbol DE; Kragstrup J; Stovring H; Havelund T; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2006 Jun; 101(6):1200-8. PubMed ID: 16771937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Helicobacter pylori in functional dyspepsia.
    O'Morain C
    World J Gastroenterol; 2006 May; 12(17):2677-80. PubMed ID: 16718752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors for dyspepsia.
    Vakil N
    Dig Dis; 2008; 26(3):215-7. PubMed ID: 18463438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulcer and gastritis.
    Wu JC; Sung JJ
    Endoscopy; 2002 Feb; 34(2):104-10. PubMed ID: 11822005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Watanabe K; Fujioka T
    J Clin Gastroenterol; 2008 Feb; 42(2):139-42. PubMed ID: 18209581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.